{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T15:13:41Z","timestamp":1788102821578,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,30]]},"DOI":"10.7759\/cureus.115439","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T14:17:51Z","timestamp":1788099471000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Metabolic Associations of Metabolic Dysfunction-Associated Steatotic Liver Disease in Young Adults: A Cross-Sectional Analysis"],"prefix":"10.7759","author":[{"given":"Prashant","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Jangid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Shafat","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayub","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Marade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abha","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobhit","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam M","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020, 158:1999-2014.e1. 10.1053\/j.gastro.2019.11.312","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al.. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023, 79:1542-56. 10.1016\/j.jhep.2023.06.003","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi ZM","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023, 77:1335-47. 10.1097\/HEP.0000000000000004","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al.. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023, 77:1797-835. 10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","unstructured":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol. 2021, 75.659-89. 10.1016\/j.jhep.2021.05.025","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30342-5","article-title":"Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission","volume":"5","author":"Sarin SK","year":"2020","unstructured":"Sarin SK, Kumar M, Eslam M, et al.. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2020, 5:167-228. 10.1016\/S2468-1253(19)30342-5","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23567","article-title":"Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease","volume":"51","author":"Das K","year":"2010","unstructured":"Das K, Das K, Mukherjee PS, et al.. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology. 2010, 51:1593-602. 10.1002\/hep.23567","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2021.11.010","article-title":"Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis","volume":"12","author":"Shalimar","year":"2022","unstructured":"Shalimar, Elhence A, Bansal B, Gupta H, Anand A, Singh TP, Goel A. Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis. J Clin Exp Hepatol. 2022, 12:818-29. 10.1016\/j.jceh.2021.11.010","journal-title":"J Clin Exp Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1595","article-title":"Obesity and the metabolic syndrome in developing countries","volume":"93","author":"Misra A","year":"2008","unstructured":"Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008, 93:S9-30. 10.1210\/jc.2008-1595","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2008.11.039","article-title":"Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome","volume":"84","author":"Mohan V","year":"2009","unstructured":"Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract. 2009, 84:84-91. 10.1016\/j.diabres.2008.11.039","journal-title":"Diabetes Res Clin Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004, 363:157-63. 10.1016\/S0140-6736(03)15268-3","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.02.003","article-title":"Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications","volume":"142","author":"Cusi K","year":"2012","unstructured":"Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology. 2012, 142:711-725.e6. 10.1053\/j.gastro.2012.02.003","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel VT","year":"2012","unstructured":"Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012, 148:852-71. 10.1016\/j.cell.2012.02.017","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo RA","year":"2015","unstructured":"DeFronzo RA, Ferrannini E, Groop L, et al.. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015, 1:15019. 10.1038\/nrdp.2015.19","journal-title":"Nat Rev Dis Primers"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven GM","year":"1988","unstructured":"Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988, 37:1595-607. 10.2337\/diab.37.12.1595","journal-title":"Diabetes"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews DR","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28:412-9. 10.1007\/BF00280883","journal-title":"Diabetologia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.04.068","article-title":"Relationship between hepatic\/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects","volume":"133","author":"Gastaldelli A","year":"2007","unstructured":"Gastaldelli A, Cusi K, Pettiti M, et al.. Relationship between hepatic\/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology. 2007, 133:496-506. 10.1053\/j.gastro.2007.04.068","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan N","year":"2019","unstructured":"Stefan N, H\u00e4ring HU, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 2019, 7:313-24. 10.1016\/S2213-8587(18)30154-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher G","year":"2010","unstructured":"Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010, 363:1341-50. 10.1056\/NEJMra0912063","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher G","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016, 65:589-600. 10.1016\/j.jhep.2016.05.013","journal-title":"J Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai PS","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, et al.. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. 2017, 65:1557-65. 10.1002\/hep.29085","journal-title":"Hepatology"},{"key":"ref22","article-title":"Waist circumference and waist-hip ratio: report of a WHO expert consultation","author":"World Health Organization","year":"2008","unstructured":"World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation. World Health Organization, Geneva; 2008."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0207-1","article-title":"A proposal for a primary screening tool: 'keep your waist circumference to less than half your height'","volume":"12","author":"Ashwell M","year":"2014","unstructured":"Ashwell M, Gibson S. A proposal for a primary screening tool: 'keep your waist circumference to less than half your height'. BMC Med. 2014, 12:207. 10.1186\/s12916-014-0207-1","journal-title":"BMC Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.08.032","article-title":"Prevalence of obesity in India: a systematic review","volume":"13","author":"Ahirwar R","year":"2019","unstructured":"Ahirwar R, Mondal PR. Prevalence of obesity in India: a systematic review. Diabetes Metab Syndr. 2019, 13:318-21. 10.1016\/j.dsx.2018.08.032","journal-title":"Diabetes Metab Syndr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-008-0011-4","article-title":"Fatty liver, insulin resistance, and dyslipidemia","volume":"8","author":"Adiels M","year":"2008","unstructured":"Adiels M, Taskinen MR, Bor\u00e9n J. Fatty liver, insulin resistance, and dyslipidemia. Curr Diab Rep. 2008, 8:60-4. 10.1007\/s11892-008-0011-4","journal-title":"Curr Diab Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/01.mol.0000236363.34734.18","article-title":"The rationale for using HDL as a therapeutic target","volume":"205","author":"Barter PJ","year":"201226","unstructured":"Barter PJ, Rye KA. The rationale for using HDL as a therapeutic target. Cardiovasc Drugs Ther. 201226, 205:212. 10.1097\/01.mol.0000236363.34734.18","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin ZH","year":"2011","unstructured":"Lin ZH, Xin YN, Dong QJ, et al.. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011, 53:726-36. 10.1002\/hep.24105","journal-title":"Hepatology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai CT","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003, 38:518-26. 10.1053\/jhep.2003.50346","journal-title":"Hepatology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","year":"2001","unstructured":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001, 285.2486-97. 10.1001\/jama.285.19.2486","journal-title":"JAMA"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2024.102466","article-title":"Prevalence of transaminitis and metabolic dysfunction-associated steatotic liver disease among young Indian adults: a population-based study","volume":"15","author":"Nair A","year":"2025","unstructured":"Nair A, Puthiyaveettil Khadar J, Mohan Preetha A, et al.. Prevalence of transaminitis and metabolic dysfunction-associated steatotic liver disease among young Indian adults: a population-based study. J Clin Exp Hepatol. 2025, 15:102466. 10.1016\/j.jceh.2024.102466","journal-title":"J Clin Exp Hepatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2024.100325","article-title":"Exploring the epidemiology and awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among health sciences students in an academic health care institute in India","volume":"24","author":"S U","year":"2024","unstructured":"S U, Aishwarya S, Aishwarya SK, Bhardwaj S, Pavithra RB, Ray S, Vinodhini VM. Exploring the epidemiology and awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among health sciences students in an academic health care institute in India. Metabol Open. 2024, 24:100325. 10.1016\/j.metop.2024.100325","journal-title":"Metabol Open"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-025-01748-1","article-title":"Prevalence of metabolic dysfunction-associated steatotic liver disease: mapping across different Indian populations (MAP Study)","volume":"16","author":"Mohan V","year":"2025","unstructured":"Mohan V, Joshi S, Kant S, et al.. Prevalence of metabolic dysfunction-associated steatotic liver disease: mapping across different Indian populations (MAP Study). Diabetes Ther. 2025, 16:1435-50. 10.1007\/s13300-025-01748-1","journal-title":"Diabetes Ther"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103645","article-title":"Effects of glucagon-like peptide-1 receptor agonists on alcohol consumption: a systematic review and meta-analysis","volume":"90","author":"Eshraghi R","year":"2025","unstructured":"Eshraghi R, Ghadimi DJ, Montazerinamin S, et al.. Effects of glucagon-like peptide-1 receptor agonists on alcohol consumption: a systematic review and meta-analysis. EClinicalMedicine. 2025, 90:103645. 10.1016\/j.eclinm.2025.103645","journal-title":"EClinicalMedicine"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/527084-clinical-and-metabolic-associations-of-metabolic-dysfunction-associated-steatotic-liver-disease-in-young-adults-a-cross-sectional-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T14:17:52Z","timestamp":1788099472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/527084-clinical-and-metabolic-associations-of-metabolic-dysfunction-associated-steatotic-liver-disease-in-young-adults-a-cross-sectional-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,30]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.115439","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,30]]}}}